A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene ( LDH , encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two proline residues (P402/ P564) located in the LXXLAP amino acid motif in the ODDD of HIF-1α were found to be good substrates for the action of a group of enzymes called prolyl-4-hydroxylases (PHDs) or HIF-1 prolyl hydroxylases (HPH)22, 28.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [22]
In the citing paper
“Oxygen sensing is mediated primarily by prolyl hydroxylase domain-containing proteins (PHDs), iron- and ascorbate-dependent enzymes in the 2-oxoglutarate (2-OG)–dependent dioxygenase family”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“These enzymes are essential for repressing HIF signaling in an oxygen-dependent manner [42,43]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“Under normoxic conditions, prolyl hydroxylase enzymes (EGLN 1–3, also known as PHD 1–3) use oxygen as a substrate to hydroxylate key proline residues within the HIF-1 and HIF-2 α subunits”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
In the citing paper
“Hypoxia activates HIF signaling by promoting the protein stability of HIF-α subunits.”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Cited by
Items 101–200 of 1,022
2-Oxoglutarate-Dependent Oxygenases
Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J., & Schofield, C. J. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044724 · Cited by 472
Aragonés, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.62 · Cited by 472
“The HIF prolyl hydroxylases (PHD1–3) are oxygen-sensitive enzymes that regulate the stability of HIFs and thereby induce cellular adaptations in response to hypoxi”
BackgroundRegulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Dioum, E. M., Chen, R., Alexander, M. S., Zhang, Q., Hogg, R. T., Gerard, R. D., & Garcia, J. A. (2009) · Science · doi:10.1126/science.1169956 · Cited by 472
Proline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Hypoxic gene expression and metastasis
Le, Q.-T., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 468
“The hydoxylase enzymes catalyze a hydroxylation reaction, which requires oxygen and 2-oxoglutarate as substrates, and iron and ascorbate as cofactors [30, 33, 34 ].”
BackgroundElvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511408200 · Cited by 464
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
“HIFalpha subunits are ydroxylated by prolyl hydroxylases (PHDs) [21] allowing HIFalha subunits to be recognized by the von Hippel–Lindau (VHL) biquitin-ligase complex [22].”
BackgroundRegulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
Blouin, C. C., Pagé, E. L., Soucy, G. M., & Richard, D. E. (2004) · Blood · doi:10.1182/blood-2003-07-2427 · Cited by 458
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0169 · Cited by 458
Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling
Nathan, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18174 · Cited by 456
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
Phototherapy in cancer treatment: strategies and challenges
Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453
Hypoxia-inducible factors: central regulators of the tumor phenotype
Gordan, J. D., & Simon, M. C. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.006 · Cited by 453
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
Clifton, I. J., McDonough, M. A., Ehrismann, D., Kershaw, N. J., Granatino, N., & Schofield, C. J. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.01.024 · Cited by 441
Bell, E. L., Emerling, B. M., Ricoult, S. J. H., & Guarente, L. (2011) · Oncogene · doi:10.1038/onc.2011.37 · Cited by 440
“This hydroxylation reaction is catalyzed by a family of proline hydroxylation enzymes (Bruick and McKnight, 2001; Epstein et al., 2001).”
BackgroundMethodInfluentialBruick, R. K. (2003) · Genes & Development · doi:10.1101/gad.1145503 · Cited by 440
“HIF-1 has been shown to play a role in promoting apoptosis under conditions of chronic hypoxia (Carmeliet et al. 1998), and the gene encoding the prodeath factor Nip3 is induced in response to hypoxia via an HRE located within its promoter (Bruick 2000).”
BackgroundSelf-citationMitochondrial complex III regulates hypoxic activation of HIF
Klimova, T., & Chandel, N. S. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402307 · Cited by 433
Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Bürgel, T., Jelkmann, W., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00318 · Cited by 432
“Another group of investigators have independently identified the same enzymes calling them HPH1, HPH2 and HPH3, where HPH stands for HIF prolyl hydroxylases (Bruick and McKnight, 2001).”
BackgroundUchida, T., Rossignol, F., Matthay, M. A., Mounier, R., Couette, S., Clottes, E., & Clerici, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400461200 · Cited by 428
Role and regulation of prolyl hydroxylase domain proteins
Fong, G.-H., & Takeda, K. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.10 · Cited by 427
“have four members belonging to this subfamily, including PHD1/EGLN2/HPH3, PHD2/EGLN1/HPH2, PHD3/EGLN3/ HPH1 and a recently characterized protein named as P4HTM.(6,7,11) Several other names have also been used for mammalian homologs, including SM-20 for rat PHD3(7) and HIF-P4H1, HIF-P4H2 and HIF-P4H3 to indicate that h…”
Hypoxia. 2. Hypoxia regulates cellular metabolism
Wheaton, W. W., & Chandel, N. S. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00485.2010 · Cited by 426
mTOR , metabolism, and the regulation of T‐cell differentiation and function
Waickman, A. T., & Powell, J. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01152.x · Cited by 420
“However, under conditions of low oxygen tension, this protein degradation pathway is strongly inhibited, thereby allowing the accumulation of HIF-1a and the formation of a transcriptionally active HIF-1 dimer (104, 105).”
BackgroundRedzic, Z. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-3 · Cited by 418
“During hypoxia, HIF-1a protein is stabilized by a decrease in activity of prolyl hydroxylases, binds to its binding partner HIF-1b, and translocates to the nucleus to bind to hypoxia-responsive cis-elements [75].”
Metabolic Shifts in Immunity and Inflammation
Kominsky, D. J., Campbell, E. L., & Colgan, S. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903002 · Cited by 416
Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
“The human enzymes have been termed prolyl hydroxylase domain containing protein 1, 2, and 3 (PHD1, PHD2, and PHD3; Epstein et al., 2001) or HIF1 prolyl hydroxylase 1, 2, and 3 (Bruick and McKnight, 2001).”
Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease
Watts, M. E., Pocock, R., & Claudianos, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00216 · Cited by 411
“HIFα protein is constitutively expressed but is immediately targeted for degradation by HIF prolyl hydroxylases (PHDs) that associate with and hydroxylate two conserved HIFα proline residues in an oxygen dependent manner (Bruick and McKnight, 2001).”
BackgroundXia, X., Lemieux, M. E., Li, W., Carroll, J. S., Brown, M., Liu, X. S., & Kung, A. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810067106 · Cited by 410
Nakayama, K., Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 405
Takeda, K., Ho, V. C., Takeda, H., Duan, L.-J., Nagy, A., & Fong, G.-H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00425-06 · Cited by 401
“The stability of the HIF-1 and HIF-2 subunits is regulated by prolyl hydroxylase domain (PHD) proteins, which are members of the 2-oxoglutarate/iron dependent dioxygenase superfamily (4, 7).”
BackgroundVEGFA is necessary for chondrocyte survival during bone development
Zelzer, E., Mamluk, R., Ferrara, N., Johnson, R. S., Schipani, E., & Olsen, B. R. (2004) · Development · doi:10.1242/dev.01053 · Cited by 401
“…Semenza and Wang, 1992; Wang and Semenza, 1993; Wang and Semenza, 1995; Zelzer et al., 1998); the tumorsuppressor protein von Hippel-Lindau (VHL) protein is a key element in this regulation (Bruick and McKnight, 2001; Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundReversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
DeBose-Boyd, R. A. (2008) · Cell Research · doi:10.1038/cr.2008.61 · Cited by 391
Elkins, J. M., Hewitson, K. S., McNeill, L. A., Seibel, J. F., Schlemminger, I., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200644200 · Cited by 391
Wu, C., & Chang, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.026 · Cited by 391
“DMOG is therefore expected to induce a hypoxic microenvironment and act as a pro-angiogenic compound [90,111,112].”
BackgroundEmerging Roles of Ubiquitin in Transcription Regulation
Conaway, R. C., Brower, C. S., & Conaway, J. W. (2002) · Science · doi:10.1126/science.1067466 · Cited by 391
Inhibition of 2-oxoglutarate dependent oxygenases
Rose, N. R., McDonough, M. A., King, O. N. F., Kawamura, A., & Schofield, C. J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00203h · Cited by 390
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 388
MARXSEN, J. H., STENGEL, P., DOEGE, K., HEIKKINEN, P., JOKILEHTO, T., WAGNER, T., JELKMANN, W., JAAKKOLA, P., & METZEN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040620 · Cited by 386
Angiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386
Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms
Pagé, E. L., Robitaille, G. A., Pouysségur, J., & Richard, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209114200 · Cited by 385
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S.-B., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 384
Molecular Biology of Erythropoietin
JELKMANN, W. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.649 · Cited by 383
Korbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910701 · Cited by 380
HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity
Semba, H., Takeda, N., Isagawa, T., Sugiura, Y., Honda, K., Wake, M., Miyazawa, H., Yamaguchi, Y., Miura, M., Jenkins, D. M. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11635 · Cited by 378
Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H., & Poellinger, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200328200 · Cited by 375
HIF1 α -Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages
Wang, T., Liu, H., Lian, G., Zhang, S.-Y., Wang, X., & Jiang, C. (2017) · Mediators of Inflammation · doi:10.1155/2017/9029327 · Cited by 371
“Macrophage activation can be altered by disrupting cellular energy metabolism [11, 12].”
BackgroundMAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370
Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 370
Understanding metabolic regulation and its influence on cell physiology
Metallo, C. M., & Vander Heiden, M. G. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.018 · Cited by 367
“M.G.V.H. is supported by the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, the Smith Family Foundation, and the National Cancer Institute.”
MethodErythropoietin after a century of research: younger than ever
Jelkmann, W. (2007) · European Journal of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 367
HIF hydroxylation and the mammalian oxygen-sensing pathway
Safran, M., & Kaelin, W. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318181 · Cited by 365
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)
McDonough, M. A., Li, V., Flashman, E., Chowdhury, R., Mohr, C., Liénard, B. M. R., Zondlo, J., Oldham, N. J., Clifton, I. J., Lewis, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601283103 · Cited by 364
HIF hydroxylation and the mammalian oxygen-sensing pathway
Safran, M., & Kaelin, W. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18181 · Cited by 363
Disparate roles of zinc in chemical hypoxia-induced neuronal death
Kim, S., Seo, J.-W., Oh, S. B., Kim, S. H., Kim, I., Suh, N., & Lee, J.-Y. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00001 · Cited by 362
“PHDs essentially require oxygen and iron for their activity, so the depletion of iron from cells could inhibit the activity of the PHDs to stabilize HIF1α from degradation, stimulating the hypoxic responses similar to that observed due to an oxygen shortage (Bruick and McKnight, 2001; Guo et al., 2001).”
BackgroundRole of Vitamin C in the Function of the Vascular Endothelium
May, J. M., & Harrison, F. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5205 · Cited by 358
Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer
Bae, T., Hallis, S. P., & Kwak, M.-K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01180-8 · Cited by 354
“Notably, mammals possess three characterized PHDs, namely, PHD1 – 3, which catalyze the hydroxylation of HIF-α subunits in the presence of Fe 2 + and α - ketoglutarate 16 .”
BackgroundTargeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 351
“The ODDD is recognized by von Hipple-Lindau (pVHL) only under normoxic conditions and pVHL is required for mediating the HIF-α degradation by ubiquitin-proteasome pathway [15,20].”
Background(2003) · PubMed · Cited by 350
Baranova, O., Miranda, L. F., Pichiule, P., Dragatsis, I., Johnson, R. S., & Chavez, J. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0449-07.2007 · Cited by 350
“…is expressed, but it is rapidly hydroxylated at two conserved proline residues; this oxygen-dependent posttranslational modification is catalyzed by the EGLN [egl nine homolog 1 (C. elegans)] family of HIF prolyl hydroxylases (Bruick and McKnight, 2001; Ivan et al., 2001; Jaakkola et al., 2001).”
BackgroundHuman high-altitude adaptation: forward genetics meets the HIF pathway
Bigham, A. W., & Lee, F. S. (2014) · Genes & Development · doi:10.1101/gad.250167.114 · Cited by 349
Hypoxic regulation of erythropoiesis and iron metabolism
Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2010 · Cited by 347
“pVHL-mediated polyubiquitylation of HIF- requires hydroxylation of specific proline residues (Pro402 and Pro564 in human HIF-1 ; Pro405 and Pro531 in human HIF-2 ) within its oxygen-dependent degradation domain (20, 35, 53, 56, 58, 94, 169).”
BackgroundStructural integration in hypoxia-inducible factors
Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F. (2015) · Nature · doi:10.1038/nature14883 · Cited by 346
Regulation of Metabolism by Hypoxia-Inducible Factor 1
Semenza, G. L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010678 · Cited by 342
Martin, F., Linden, T., Katschinski, D. M., Oehme, F., Flamme, I., Mukhopadhyay, C. K., Eckhardt, K., Tröger, J., Barth, S., Camenisch, G., et al. (2005) · Blood · doi:10.1182/blood-2004-10-3980 · Cited by 341
Beyer, S., Kristensen, M. M., Jensen, K. S., Johansen, J. V., & Staller, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804578200 · Cited by 340
Branching Morphogenesis of the Drosophila Tracheal System
Ghabrial, A., Luschnig, S., Metzstein, M. M., & Krasnow, M. A. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.031403.160043 · Cited by 337
“…cognates of HIF pathway components including the HIFα (sima) and ß (tango) subunits have been identified (Nagao et al. 1996, Adryan et al. 2000, Bruick & McKnight 2001, Lavista-Llanos et al. 2002), and the pathway is present in larvae and activated by hypoxia, as in the mammalian pathway…”
BackgroundThe von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Kaelin, W. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1865 · Cited by 336
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Wallace, E. M., Rizzi, J. P., Han, G., Wehn, P. M., Cao, Z., Du, X., Cheng, T., Czerwinski, R. M., Dixon, D. D., Goggin, B. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0473 · Cited by 336
Kaelin, W. G. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092049 · Cited by 336
Direct Interactions between HIF-1α and Mdm2 Modulate p53 Function
Chen, D., Li, M., Luo, J., & Gu, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200694200 · Cited by 334
Pan, Y., Mansfield, K. D., Bertozzi, C. C., Rudenko, V., Chan, D. A., Giaccia, A. J., & Simon, M. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01223-06 · Cited by 332
“HIF- protein turnover is ensured by hydroxylation of critical proline residues within the oxygendependent degradation domains (ODDs) (23), allowing their association with von Hippel-Lindau protein (pVHL)-containing E3 ubiquitin ligase complexes ( 7 , 16, 21, 27, 28, 44, 58).”
BackgroundMitochondrial reactive oxygen species regulate hypoxic signaling
Hamanaka, R. B., & Chandel, N. S. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.005 · Cited by 332
“This hydroxylation reaction is carried out by a family of 2-oxoglutarate-dependent dioxygenases termed prolyl hydroxylases 1, 2, and 3 (PHD1–3) [26,27].”
BackgroundPercy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508423103 · Cited by 330
Generating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 330
Biology of hypoxia-inducible factor-2α in development and disease
Patel, S. A., & Simon, M. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.17 · Cited by 327
Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
Fraisl, P., Aragonés, J., & Carmeliet, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2761 · Cited by 326
Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase
Hoffart, L. M., Barr, E. W., Guyer, R. B., Bollinger, J. M., & Krebs, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604005103 · Cited by 324
Hypoxia is a major stimulator of osteoclast formation and bone resorption
Arnett, T. R., Gibbons, D. C., Utting, J. C., Orriss, I. R., Hoebertz, A., Rosendaal, M., & Meghji, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10321 · Cited by 323
“…on hypoxia-induced factor (HIF), a constitutively-produced transcription factor that mediates cellular responses to hypoxia; proline hydroxylation in the presence of oxygen serves to target HIF for intracellular destruction, preventing its action (Bruick and McKnight, 2001; Jaakkola et al., 2001).”
BackgroundSalnikow, K., Donald, S. P., Bruick, R. K., Zhitkovich, A., Phang, J. M., & Kasprzak, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403057200 · Cited by 319
Self-citationThe Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Kaelin, W. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-sup-040025 · Cited by 318
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, L. E., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Koury, M. J., & Haase, V. H. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.82 · Cited by 313
Lahiri, S., Roy, A., Baby, S. M., Hoshi, T., Semenza, G. L., & Prabhakar, N. R. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2005.07.001 · Cited by 312
Mechanisms of hypoxia signalling: new implications for nephrology
Schödel, J., & Ratcliffe, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0182-z · Cited by 309
Huang, J., Zhao, Q., Mooney, S. M., & Lee, F. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206955200 · Cited by 307
Investigating hypoxic tumor physiology through gene expression patterns
Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R., & Giaccia, A. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206703 · Cited by 305
Erythropoietin and the hypoxic brain
Marti, H. H. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01049 · Cited by 303
Tumor hypoxia and cancer progression
Zhou, J., Schmid, T., Schnitzer, S., & Brüne, B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.028 · Cited by 302
Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., & Melillo, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3139 · Cited by 301
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Scheuermann, T. H., Tomchick, D. R., Machius, M., Guo, Y., Bruick, R. K., & Gardner, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808092106 · Cited by 301
“The best characterized of these modifications are hydroxylations of key proline and asparagine residues in the HIF C-terminal region (11, 12).”
BackgroundSelf-citationmTOR Pathways in Cancer and Autophagy
Paquette, M., El-Houjeiri, L., & Pause, A. (2018) · Cancers · doi:10.3390/cancers10010018 · Cited by 297
“In contrast, HIF is targeted for degradation in normoxic conditions via the prolyl 4-hydroxylases (PHD) and the von Hippel-Lindau tumour suppressor protein (VHL) [68,69].”
BackgroundReactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
Kietzmann, T., & Görlach, A. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.010 · Cited by 295
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
Pollard, P. J., Loenarz, C., Mole, D. R., McDonough, M. A., Gleadle, J. M., Schofield, C. J., & Ratcliffe, P. J. (2008) · Biochemical Journal · doi:10.1042/bj20081238 · Cited by 295
Preconditional Activation of Hypoxia-Inducible Factors Ameliorates Ischemic Acute Renal Failure
Bernhardt, W. M., Ca[Combining Circumflex Accent]mpean, V., Kany, S., Ju[Combining Diaeresis]rgensen, J.-S., Weidemann, A., Warnecke, C., Arend, M., Klaus, S., Gu[Combining Diaeresis]nzler, V., Amann, K., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121302 · Cited by 295
“At least three different PHD have been identified so far (6,7), termed PHD1, PHD2, and PHD3, but their relative contribution to HIF- regulation still remains to be clarified.”
BackgroundSomatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T., & Kaelin, W. G. (2008) · Blood · doi:10.1182/blood-2007-10-117812 · Cited by 294
Oxygen sensing and hypoxia signalling pathways in animals: The implications of physiology for cancer
Ratcliffe, P. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.251470 · Cited by 294
Metadata
- Authors
- Bruick, R. K., & McKnight, S. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- McKnight, Steven L.
- ORCID
- McKnight, Steven L.
- Venue
- Science
- Published
- 2001-11-09
- Volume
- 294
- Issue
- 5545
- Pages
- 1337-1340
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2042216712
- Cited by
- 2,549
- References
- 27
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 67 · 2023: 65 · 2022: 90 · 2021: 95 · 2020: 80 · 2019: 90 · 2018: 103 · 2017: 98 · 2016: 113 · 2015: 109 · 2014: 104 · 2013: 115 · 2012: 114
- FWCI
- 42.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- prolyl 4-hydroxylase, hypoxia-inducible factor, HIF-1α, oxygen sensing, proline hydroxylation, protein degradation, ubiquitin ligase, post-translational modification, lactate dehydrogenase, Drosophila melanogaster, normoxia
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Drosophila melanogaster, Humans, Hydroxylation, Hydroxyproline, L-Lactate Dehydrogenase, Molecular Sequence Data, Mutation, Nuclear Proteins, Oxygen, Procollagen-Proline Dioxygenase, Recombinant Proteins, RNA, Double-Stranded, Substrate Specificity, Transcription Factors, Transfection, Cell Hypoxia, Gene Expression Regulation, Enzymologic, Sequence Alignment, Conserved Sequence, Genes, Insect, Genes, Reporter, Amino Acid Substitution, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.